In both the subsets, the decrease in glucose levels compared to baseline was found to be highly significant already at T3, as well as after 6 and 12 months of therapy ( Tables 3 and 4 ).
← all excerpts
Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience.
1
—
—